Document Detail

Cerebral β-amyloid detected by Pittsburgh compound B positron emission topography predisposes to recombinant tissue plasminogen activator-related hemorrhage.
MedLine Citation:
PMID:  20661925     Owner:  NLM     Status:  MEDLINE    
Cerebral amyloid angiopathy (CAA) may be an important predisposing factor for the hemorrhagic complications of recombinant tissue-type plasminogen activator (rt-PA) therapy. We studied patients treated within 3 hours of onset of ischemic stroke with rt-PA using positron emission tomography to compare Pittsburgh compound B (PiB) (a cerebral β-amyloid ligand) retention in those with and without parenchymal hemorrhage (PH) and normal controls. Neocortical PiB retention was higher among patients with PH compared with patients without PH and normal controls, suggesting underlying CAA as a predisposing factor for rt-PA-related hemorrhage. This finding may provide an impetus for the development of a more practical rapid pretreatment screening technique.
John V Ly; Christopher C Rowe; Victor L Villemagne; Jorge A Zavala; Henry Ma; Graeme O'Keefe; Sylvia J Gong; Rico Gunawan; Leonid Churilov; Tim Saunder; Uwe Ackerman; Henri Tochon-Danguy; Geoffrey A Donnan
Related Documents :
25338515 - Abdominal wall thickness is not useful to predict appendix visualization on sonography ...
25366635 - Early diagnosis of cerebral ischemia in cerebral vasospasm by oxygen-pulse near-infrare...
11515505 - Mri features of primary central nervous system lymphomas at presentation.
25424435 - Different electrophysiological profiles and treatment response in 'typical' and 'atypic...
14556645 - Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease p...
23937985 - Absolute monocyte count trichotomizes chronic lymphocytic leukemia into high risk patie...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Annals of neurology     Volume:  68     ISSN:  1531-8249     ISO Abbreviation:  Ann. Neurol.     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2011-01-03     Completed Date:  2011-01-31     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7707449     Medline TA:  Ann Neurol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  959-62     Citation Subset:  IM    
National Stroke Research Institute, Austin Health, University of Melbourne, Heidelberg Heights, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Benzothiazoles / diagnostic use*
Cerebral Amyloid Angiopathy / etiology,  radionuclide imaging*
Fibrinolytic Agents / adverse effects*
Hemorrhage / chemically induced*,  complications*
Magnetic Resonance Imaging / methods
Positron-Emission Tomography / methods
ROC Curve
Retrospective Studies
Stroke / drug therapy
Tissue Plasminogen Activator / adverse effects*
Reg. No./Substance:
0/Benzothiazoles; 0/Fibrinolytic Agents; 0/N-methyl-2-(4'-methylaminophenyl)-6-hydroxybenzothiazole; EC Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Reciprocal Th1 and Th17 regulation by mesenchymal stem cells: Implication for multiple sclerosis.
Next Document:  Does exercise correct dysregulation of neurosteroid levels induced by epilepsy?